Indian Journal of Sleep Medicine

Register      Login

VOLUME 3 , ISSUE 3 ( July-September, 2008 ) > List of Articles

REVIEW ARTICLE

Sleep Disorders in Neurological Diseases

Manjari Tripathi, S. Sachin

Citation Information : Tripathi M, Sachin S. Sleep Disorders in Neurological Diseases. Indian Sleep Med 2008; 3 (3):78-84.

DOI: 10.5005/ijsm-3-3-78

License: CC BY-SA 4.0

Published Online: 01-07-2008

Copyright Statement:  Copyright © 2008; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Tandberg E, Larsen JP, Karlsen K. Excessive daytime sleepiness and sleep benefit in Parkinson's disease: a community-based study. Mov Disord. 1999 ;14:922-7.
  2. Tan EK, Lum SY, Fook-Chong SM, Teoh ML, Yih Y, Tan L, Tan A, Wong MC. Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls. Neurology. 2002;58:465-8.
  3. Kumar S, Bhatia M, Behari M. Sleep disorders in Parkinson's disease. Mov Disord. 2002 ;17:775-81
  4. Baumann CR, Scammell TE, Bassetti CL. Parkinson's disease, sleepiness and hypocretin/orexin. Brain. 2008;131:e91.
  5. Ghorayeb I, Yekhlef F, Chrysostome V, Balestre E, Bioulac B, Tison F. Sleep disorders and their determinants in multiple system atrophy. J Neurol Neurosurg Psychiatry. 2002;72:798-800
  6. Biglan KM, Holloway RG Jr, McDermott MP, Richard IH; Parkinson Study Group CALM-PD Investigators. Risk factors for somnolence, edema, and hallucinations in early Parkinson disease. Neurology. 2007 ;69:187-95
  7. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?Neurology. 2006;67:853-8.
  8. Iranzo A, Molinuevo JL, Santamaría J, Serradell M, Martí MJ, Valldeoriola F, Tolosa E. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol. 2006 ;5:572-7.
  9. Schenck CH, Bundlie SR, Mahowald MW.Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology. 1996; 46: 388-93.
  10. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain. 2000 ;123 :331-9
  11. Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P, Lugaresi E, Cortelli P. REM sleep behavior disorders in multiple system atrophy. Neurology. 1997;48:1094-7.
  12. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K.Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004 ;318:121-34.
  13. Schmeichel AM, Buchhalter LC, Low PA, Parisi JE, Boeve BW, Sandroni P, Benarroch EE. Mesopontine cholinergic neuron involvement in Lewy body dementia and multiple
  14. Neurology. 2008 ;70:368-73
  15. Piperidou C, Karlovasitou A, Triantafyllou N, Terzoudi A, Constantinidis T, Vadikolias K, Heliopoulos I, Vassilopoulos D, Balogiannis S.Influence of sleep disturbance on quality of life of patients with epilepsy. Seizure. 2008 Apr 5
  16. Khatami R, Zutter D, Siegel A, Mathis J, Donati F, Bassetti CL.Sleep-wake habits and disorders in a series of 100 adult epilepsy patients - a prospective study. Seizure. 2006; 15: 299-306
  17. Vignatelli L, Bisulli F, Naldi I, Ferioli S, Pittau F, Provini F, Plazzi G, Vetrugno R, Montagna P, Tinuper P. Excessive daytime sleepiness and subjective sleep quality in patients with nocturnal frontal lobe epilepsy: a case-control study. Epilepsia. 2006; 47 Suppl 5:73-7
  18. Weatherwax KJ, Lin X, Marzec ML, Malow BA. Obstructive sleep apnea in epilepsy patients: the Sleep Apnea scale of the Sleep Disorders Questionnaire (SA-SDQ) is a useful screening instrument for obstructive sleep apnea in a disease-specific population. Sleep Med. 2003 ;4:517-21
  19. Malow BA, Levy K, Maturen K, Bowes R. Obstructive sleep apnea is common in medically refractory epilepsy patients. Neurology. 2000; 55:1002-7.
  20. Vaughn BV, D'Cruz O, Beach R, Messenheimer JA. Improvement of epileptic seizure control with treatment of obstructive sleep apnoea. Seizure 1996; 5: 73–78
  21. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999; 22: 217–223
  22. Pradeep Kumar VG, Bhatia M, Tripathi M, Srivastava AK, Jain S. Obstructive sleep apnoea: a case-control study. Neurol India. 2003 ;51:497-9
  23. McArdle N, Riha RL, Vennelle M, Coleman EL, Dennis MS, Warlow CP, Douglas NJ. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transient ischemic attacks. Stroke. 2003; 34:2916-21.
  24. Parra O, Arboix A, Bechich S, Garcia-Eroles L, Montserrat JM, Lopez JA, Ballester E, Guerra JM, Sopena JJ. Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. Am J Respir Crit Care Med. 2000; 161:375–380
  25. Dziewas R, Hopmann B, Humpert M, Ritter M, Dittrich R, Schäbitz WR, Ringelstein EB, Nabavi DG, Young P. Positional sleep apnea in patients with ischemic stroke. Neurol Res. 2008;30:645-8
  26. Iranzo A, Santamaria J, Berenguer J, Sanchez M, Chamorro A. Prevalence and clinical importance of sleep apnea in the first night after cerebral infarction. Neurology. 2002; 58: 911–916
  27. Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, Marriott A, Nobili F, Robert P, Tsolaki M, Vellas B, Verhey F, Byrne EJ. Clustering of behavioural and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study. Acta Clin Belg. 2007; 62:426-32
  28. Ohadinia S, Noroozian M, Shahsavand S, Saghafi S. Evaluation of insomnia and daytime napping in Iranian Alzheimer disease patients: relationship with severity of dementia and comparison with normal adults. Am J Geriatr Psychiatry. 2004;12:517-22
  29. Lee JH, Bliwise DL, Ansari FP, Goldstein FC, Cellar JS, Lah JJ, Levey AI. Daytime sleepiness and functional impairment in Alzheimer disease. Am J Geriatr Psychiatry. 2007;15:620-6
  30. Harper DG, Volicer L, Stopa EG, McKee AC, Nitta M, Satlin A. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am J Geriatr Psychiatry. 2005;13:359-68.
  31. Liu HC, Hu CJ, Tang YC, Chang JG. A pilot study for circadian gene disturbance in dementia patients. Neurosci Lett. 2008;435:229-33
  32. Wu YH, Fischer DF, Kalsbeek A, Garidou-Boof ML, van der Vliet J, van Heijningen C, Liu RY, Zhou JN, Swaab DF. Pineal clock gene oscillation is disturbed in Alzheimer's disease, due to functional disconnection from the “master clock”. FASEB J. 2006;20:1874-6.
  33. Yamakawa M, Shigenobu K, Makimoto K, Zhu C, Ashida N, Tabushi K. Environmental Control Interventions for Frontotemporal Dementia With Reversed Sleep-Wake Cycles. Am J Alzheimers Dis Other Demen. 2008 Jun 30. [Epub ahead of print]
  34. McCurry SM, Reynolds CF, Ancoli-Israel S, Teri L, Vitiello MV. Treatment of sleep disturbance in Alzheimer's disease. Sleep Med Rev. 2000 ;4:603-628.
  35. Schmidt, S Cohrs, T Heinemann, C Goerdt, M Djukic, B Heimann, C-W Wallesch, and R NauSleep disorders are long-term sequelae of both bacterial and viral meningitis. J. Neurol. Neurosurg. Psychiatry, Apr 2006; 77: 554 - 558.
  36. Hodgson A, Smith T, Gagneux S, Akumah I, Adjuik M, Pluschke G, Binka F, Genton B.Survival and sequelae of meningococcal meningitis in Ghana. Int J Epidemiol. 2001; 30:1440-6
  37. Fukutake T, Shinotoh H, Nishino H, et al. Homozygous Machado-Joseph disease presenting as REM sleep behaviour disorder and prominent psychiatric symptoms. Eur J Neurol 2002; 9:97–100
  38. Niakan E, Bertorini TE, Lemmi H, Medeiros M, Drewry R, Kish E. Spinocerebellar degeneration and slow saccades in three generations of a kinship: clinical and electrophysiologic findings. Ar Qneuropsiquiatr 1984;42:232–241
  39. Tuin I, Voss U, Kang JS, Kessler K, Rüb U, Nolte D, Lochmüller H, Tinschert S, Claus D, Krakow K, Pflug B, Steinmetz H, Auburger G. Stages of sleep pathology in spinocerebellar ataxia type 2 (SCA2).Neurology. 2006 ;67:1966-72
  40. Osorio I, Daroff RB. Absence of REM and altered NREM sleep in patients with spinocerebellar degeneration and slow saccades. Ann Neurol 1980;7:277–280
  41. Laberge L, Begin P, Montplaisir J, Mathieu J. Sleep complaints in patients with myotonic dystrophy. J Sleep Res 2004;13:95–100
  42. Rubinsztein JS, Rubinsztein S, Goodburn S, Holland AJ. Apathy and hypersomnia are common features of myotonic dystrophy. J Neurol Neurosurg Psychiatry 1998;64:510–
  43. Khandelwal D, Bhatia M, Tripathi M, Sahota P, Jain S.Excessive daytime sleepiness: an unusual presentation of myotonic dystrophy. Sleep Med. 2002;3:431-2
  44. Martínez-Rodríguez JE, Lin L, Iranzo A, Genis D, Martí MJ, Santamaria J, Mignot E. Decreased hypocretin-1 (Orexin- A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep. 2003 ;26:287-90.
  45. Ciafaloni E, Mignot E, Sansone V, Hilbert JE, Lin L, Lin X, Liu LC, Pigeon WR, Perlis ML, Thornton CA.The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology. 2008;70:226-30
  46. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Molec Genetics 2004; 13:3079–3088
  47. Vetrugno R, Stecchi S, Plazzi G, Lodi R, D'Angelo R, Alessandria M, Cortelli P, Montagna P. Narcolepsy-like syndrome in multiple sclerosis. Sleep Med. 2008 Jun 10
  48. Gómez-Choco MJ, Iranzo A, Blanco Y, Graus F, Santamaria J, Saiz A. Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis. Mult Scler. 2007;13:805-8.
  49. Kelman L, Rains JC. Headache and sleep: examination of sleep patterns and complaints in a large clinical sample of migraineurs. Headache. 2005 Jul-Aug;45(7):904-10
  50. Alstadhaug K, Salvesen R, Bekkelund S. Insomnia and circadian variation of attacks in episodic migraine. Headache. 2007 Sep; 47(8):1184-8.
  51. Arnulf I, Nielsen J, Lohmann E, Schieffer J, Wild E, Jennum P, Konofal E, Walker M, Oudiette D, Tabrizi S, Durr A. Rapid eye movement sleep disturbances in Huntington disease. Arch Neurol. 2008 ;65:482-8.
  52. Morton AJ, Wood NI, Hastings MH, Hurelbrink C, Barker RA, Maywood ES. Disintegration of the sleep-wake cycle and circadian timing in Huntington's disease. J Neurosci. 2005; 25:157-63
  53. Valentino RM, Foldvary-Schaefer N.Modafinil in the treatment of excessive daytime sleepiness. Cleve Clin J Med. 2007 Aug;74(8):561-6, 568-71
  54. Nishino S, Okuro M. Armodafinil for excessive daytime sleepiness. Drugs Today (Barc). 2008; 44:395-414
  55. Gagnon JF, Postuma RB, Montplaisir J. Update on the pharmacology of REM sleep behavior disorder. Neurology. 2006 Sep 12;67(5):742-7
  56. Hui DS, Choy DK, Wong LK, Ko FW, Li TS, Woo J, Kay R. Prevalence of sleep-disordered breathing and continuous positive airway pressure compliance: results in chinese patients with first-ever ischemic stroke. Chest. 2002;122:852-60.
  57. Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ; Alzheimer's Disease Cooperative Study. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease. Sleep. 2003; 26:893-901
  58. Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behav Sleep Med. 2003;1:22-36
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.